PROKIDNEY CORP (PROK) Stock Income Statement
NASDAQ:PROK - Nasdaq - KYG7S53R1049 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 306.00K | 76.00K | 0.00 | 0.00 | 0.00 | |||
| Minority Interest Expense | 97.53M | 102.15M | 99.98M | 40.10M | N/A | |||
| Operating Expenses | 185.29M | 178.43M | 151.52M | 153.01M | 55.11M | |||
| Research and Development | 127.70M | 127.67M | 106.71M | 82.07M | 46.26M | |||
| Selling, General, and Administrative Expenses | 57.60M | 50.76M | 44.81M | 70.94M | 8.86M | |||
| Operating Income | -184.99M | -178.35M | -151.52M | -153.01M | -55.11M | |||
| Interest Income/Expense | 18.93M | 19.74M | 22.07M | 5.77M | 0.00 | |||
| Non Recurring Items | N/A | -5.32M | N/A | N/A | N/A | |||
| Income Before Taxes | -166.06M | -163.93M | -129.45M | -147.24M | -55.11M | |||
| Income Tax | -105.00K | -598.00K | 6.00M | 900.00K | 40.00K | |||
| Net Income | -68.43M | -61.19M | -35.47M | -108.03M | -55.15M | |||
| EBITDA | -179.06M | -172.92M | -147.67M | -149.97M | -53.13M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.60 | -0.62 | -0.57 | -1.76 | -0.90 | |||
| Non GAAP EPS | -0.60 | -0.63 | -0.57 | N/A | N/A | |||
| Statistics | ||||||||
| Profit Margin | -22362.09% | -80507.89% | N/A | N/A | N/A | |||
| Operating Profit Margin | -60453.59% | -234673.68% | N/A | N/A | N/A | |||
All data in USD